A project to develop a small portable device to detect the coronavirus in airports, railway stations and public spaces where rapid screening could contribute to early detection of the disease has been awarded a Swiss National Science Foundation grant.
“There is an urgent need for a set of measures to control the spread of the virus, reduce the severity of the disease in infected patients and ultimately prevent infection with effective vaccines,” said the Swiss Federal Institute of Technology Lausanne (EPFL)’s Sandrine Gerber, who is leading the research.
“With a low-cost and highly sensitive biosensor, we are proposing an approach to overcome the limitations of current testing procedures, which should eliminate the need for biomedical staff and specialized laboratory infrastructure,” she said in an EPFL statement on FridayExternal link.
Also participating in the project is Igor Stefanini from the University of Applied Sciences and Arts of Southern Switzerland (SUPSI) und Francesco Bertoni from Università della Svizzera italiana (USI).
The detector project is one of two from the EPFL to be awarded a grant. The other involves large-scale serological profiling of Covid-19 using high-throughput microfluidic immunological nano-assays, the statement said.
In all, 28 new coronavirus research projects have been funded under the SNSF Covid-19 National Research Programme launched on April 30 to “advance our understanding of the coronavirus disease 2019”.
Total grants were worth CHF18.6 million ($20.3 million), the SNSF saidExternal link earlier this week.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This content was published on
Solar energy pioneer Raphaël Domjan and his team continued preparations for the altitude record attempt at 10,000 metres with the SolarStratos solar aircraft.
This content was published on
Cattle in the canton of Geneva and in the neighbouring region of Terre Sainte in the canton of Vaud are being vaccinated against the contagious viral skin nodule disease. The first cases of the animal disease were reported at the end of June in France, just outside Geneva.
Fewer attacks on Swiss ATMs but their future remains uncertain
This content was published on
Bank ATMs in Switzerland are less prone to attacks by criminals, but their future remains uncertain given the less active use of cash by the population.
This content was published on
A series of rockfalls occurred above the village of Brienz between 9 and 12 July. According to the municipality of Albula, the overall situation remains tense. Several people disregarded the ban on entering the area around the village.
This content was published on
Arosa Bergbahnen achieved the highest figure in its 95-year history in the 2024/25 financial year with net revenue of CHF 37 million. Arosa Lenzerheide was able to capitalise on strengths such as snow reliability and the size of the ski area in a long winter season, the company announced on Thursday.
This content was published on
Unknown perpetrators stole ceramic dental implants during a break-in at a company in Oensingen, northern Switzerland, on Tuesday night.
Euro 2025: Bern prepares for massive parade ahead of Switzerland-Spain game
This content was published on
The last Euro 2025 match to be played in Bern, the quarterfinal between Spain and Switzerland at 9pm on Friday, promises to be a great celebration of football.
Clariant faces further ethylene price-fixing claim
This content was published on
Swiss chemicals group Clariant is facing a further claim for damages in connection with ethylene price-fixing agreements.
This content was published on
The Grande Dixence dam in Lower Valais is closed to visitors due to a rockfall last weekend. The nearby hotel also had to temporarily suspend operations for safety reasons.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
Report finds most returnees from Covid-19 risk countries avoid quarantine
This content was published on
Less than half of all people returning to Switzerland from at risk countries are complying with quarantine rules, according to a news report.
Lausanne hospital test chosen for coronavirus study
This content was published on
A test developed at Lausanne university hospital has been chosen for wide-scale coronavirus antibody studies of the Swiss population.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.